Apex Biotechnology Corp (1733) — Capital Reinvestment Ratio
Apex Biotechnology Corp (1733) has a Capital Reinvestment Ratio of 0.57x as of September 2025, meaning it reinvests 1% of its operating cash flow (NT$5.19 Million) in capital expenditures (NT$2.97 Million). Check 1733 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Apex Biotechnology Corp Capital Reinvestment Ratio (2002–2024)
This chart tracks Apex Biotechnology Corp's Capital Reinvestment Ratio across 23 annual periods. For the full cash flow conversion analysis, see Apex Biotechnology Corp (1733) cash conversion ratio.
Annual Capital Reinvestment Ratio for Apex Biotechnology Corp (2002–2024)
Year-by-year Capital Reinvestment Ratio for Apex Biotechnology Corp from 2002 to 2024. See 1733 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | NT$328.67 Million | NT$29.63 Million | ▼ -16.8% |
| 2023 | 0.11x | NT$230.39 Million | NT$24.98 Million | ▼ -92.8% |
| 2022 | 1.51x | NT$26.62 Million | NT$40.20 Million | ▲ +936.9% |
| 2021 | 0.15x | NT$179.87 Million | NT$26.20 Million | ▼ -15.4% |
| 2020 | 0.17x | NT$280.60 Million | NT$48.32 Million | ▲ +40.8% |
| 2019 | 0.12x | NT$462.52 Million | NT$56.58 Million | ▼ -89.0% |
| 2018 | 1.11x | NT$67.57 Million | NT$75.29 Million | ▲ +194.9% |
| 2017 | 0.38x | NT$70.83 Million | NT$26.76 Million | ▲ +192.8% |
| 2016 | 0.13x | NT$298.06 Million | NT$38.45 Million | ▲ +128.5% |
| 2015 | 0.06x | NT$472.15 Million | NT$26.66 Million | ▼ -76.9% |
| 2014 | 0.24x | NT$267.60 Million | NT$65.41 Million | ▼ -52.2% |
| 2013 | 0.51x | NT$484.77 Million | NT$247.69 Million | ▼ -37.2% |
| 2012 | 0.81x | NT$509.67 Million | NT$414.70 Million | ▲ +198.1% |
| 2011 | 0.27x | NT$273.45 Million | NT$74.63 Million | ▼ -21.1% |
| 2010 | 0.35x | NT$465.59 Million | NT$161.05 Million | ▲ +84.6% |
| 2009 | 0.19x | NT$391.29 Million | NT$73.34 Million | ▼ -56.7% |
| 2008 | 0.43x | NT$299.96 Million | NT$129.74 Million | ▲ +188.3% |
| 2007 | 0.15x | NT$364.62 Million | NT$54.71 Million | ▲ +30.0% |
| 2006 | 0.12x | NT$363.71 Million | NT$41.99 Million | ▼ -69.9% |
| 2005 | 0.38x | NT$212.14 Million | NT$81.30 Million | ▼ -66.7% |
| 2004 | 1.15x | NT$218.54 Million | NT$251.16 Million | ▲ +518.0% |
| 2003 | 0.19x | NT$302.25 Million | NT$56.21 Million | ▼ -75.8% |
| 2002 | 0.77x | NT$79.49 Million | NT$61.13 Million | — |